Johnson and Johnson

Deadlock on Indemnity Clause Keeps US Vaccines From Indian Market

CDSCO Expert Panel Gives Nod to Study on Mixing Doses of Covaxin, Covishield

India ‘Close’ To Giving Indemnity to Foreign Vaccine Makers Like Pfizer

Centre Won’t Import COVID-19 Vaccines, Will Leave It to States, Companies

J&J Seeks Permission To Conduct Phase 3 Trials of Its COVID Vaccine in India

Covishield Blood Clot Risk Minuscule but Govt Not Transparent: Gagandeep Kang

India’s Other COVID-19 Vaccines Held Up By Shortage of Raw Materials, Data